Combined lesions of direct and indirect basal ganglia pathways but not changes in dopamine levels explain learning deficits in patients with Huntington's disease

被引:18
|
作者
Schroll, Henning [1 ,2 ,3 ,4 ]
Beste, Christian [5 ]
Hamker, Fred H. [2 ,4 ]
机构
[1] Charite, Neurol, D-13353 Berlin, Germany
[2] Charite, Bernstein Ctr Computat Neurosci, D-13353 Berlin, Germany
[3] Humboldt Univ, Psychol, D-10099 Berlin, Germany
[4] Tech Univ Chemnitz, Comp Sci, D-09111 Chemnitz, Germany
[5] Tech Univ Dresden, Fac Med, Dept Child & Adolescent Psychiat, Cognit Neurophysiol, Dresden, Germany
关键词
computational modeling; dopamine; neurodegeneration; stimulus-response learning; striatum; SUBTHALAMIC NUCLEUS; RESPONSE-INHIBITION; PROJECTION NEURONS; TRACK-HD; MECHANISMS; MODELS; PREMANIFEST; DISSOCIATION; METABOLISM; DISORDERS;
D O I
10.1111/ejn.12868
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a hereditary neurodegenerative disease of the basal ganglia that causes severe motor, cognitive and emotional dysfunctions. In the human basal ganglia, these dysfunctions are accompanied by a loss of striatal medium spiny neurons, dysfunctions of the subthalamic nucleus and globus pallidus, and changes in dopamine receptor binding. Here, we used a neuro-computational model to investigate which of these basal ganglia dysfunctions can explain patients' deficits in different stimulus-response learning paradigms. We show that these paradigms are particularly suitable for scrutinising the effects of potential changes in dopamine signaling and of potential basal ganglia lesions on overt behavior in HD. We find that combined lesions of direct and indirect basal ganglia pathways, but none of these lesions alone, reproduce patients' learning impairments. Degeneration of medium spiny neurons of the direct pathway accounts for patients' deficits in facilitating correct responses, whereas degeneration of indirect pathway medium spiny neurons explains their impairments in inhibiting dominant but incorrect responses. The empirical results cannot be explained by lesions of the subthalamic nucleus, which is part of the hyperdirect pathway, or by changes in dopamine levels. Overall, our simulations suggest combined lesions of direct and indirect pathways as a major source of HD patients' learning impairments and, tentatively, also their motor and cognitive deficits in general, whereas changes in dopamine levels are suggested to not be causally related to patients' impairments.
引用
收藏
页码:1227 / 1244
页数:18
相关论文
共 47 条
  • [41] Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease
    Lastres-Becker, I
    Berrendero, F
    Lucas, JJ
    Martín-Aparicio, E
    Yamamoto, A
    Ramos, JA
    Fernández-Ruiz, JJ
    BRAIN RESEARCH, 2002, 929 (02) : 236 - 242
  • [42] Screening Patients with Early Stage Parkinson's Disease Using a Machine Learning Technique: Measuring the Amount of Iron in the Basal Ganglia
    Lee, Seon
    Oh, Se-Hong
    Park, Sun-Won
    Shin, Chaewon
    Kim, Jeehun
    Rhim, Jung-Hyo
    Lee, Jee-Young
    Choi, Joon-Yul
    APPLIED SCIENCES-BASEL, 2020, 10 (23): : 1 - 13
  • [43] Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease
    Bagetta, Vincenza
    Picconi, Barbara
    Marinucci, Silvia
    Sgobio, Carmelo
    Pendolino, Valentina
    Ghiglieri, Veronica
    Fusco, Francesca R.
    Giampa, Carmen
    Calabresi, Paolo
    JOURNAL OF NEUROSCIENCE, 2011, 31 (35): : 12513 - 12522
  • [44] Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication
    Swainson, R
    Rogers, RD
    Sahakian, BJ
    Summers, BA
    Polkey, CE
    Robbins, TW
    NEUROPSYCHOLOGIA, 2000, 38 (05) : 596 - 612
  • [45] Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients:: Positron emission tomographic studies
    Koochesfahani, Kaveh M.
    de la Fuente-Fernandez, Raul
    Sossi, Vesna
    Schulzer, Michael
    Yatham, Lakshmi N.
    Ruth, Thomas J.
    Blinder, Stephan
    Stoessl, A. Jon
    MOVEMENT DISORDERS, 2006, 21 (07) : 970 - 975
  • [46] AAV2:2.retro-Mediated Delivery of Mutant Huntingtin throughout Cortico-Basal Ganglia Circuitry Leads to the Progressive Development of Motor and Cognitive Decline, along with Microstructural Changes in White and Gray Matter, in a Novel Rhesus Macaque Model of Huntington's Disease
    Weiss, Alison R.
    Liguore, William A.
    Brandon, Kristin
    Wang, Xiaojie
    Liu, Zheng
    Domire, Jackie
    Button, Dana
    Kroenke, Christopher D.
    McBride, Jodi L.
    MOLECULAR THERAPY, 2021, 29 (04) : 33 - 34
  • [47] Evaluation of basal ganglia haemodynamic changes with perfusion-weighted magnetic resonance imaging in patients with Parkinson's disease [Valutazione delle modificazioni emodinamiche a livello dei gangli della base mediante risonanza magnetica perfusionale nel soggetti affetti da morbo di Parkinson]
    Gaudiello F.
    Garaci F.G.
    Marziali S.
    Ludovici A.
    Brusa L.
    Stanzione P.
    Floris R.
    Simonetti G.
    La radiologia medica, 2006, 111 (2) : 284 - 290